Protalix BioTherapeutics
PLX
PLX
43 hedge funds and large institutions have $76.5M invested in Protalix BioTherapeutics in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $120M → $76.5M (-$43.9M)
84% less call options, than puts
Call options by funds: $101K | Put options by funds: $627K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
43
Holding in Top 10
–
Calls
$101K
Puts
$627K
Top Buyers
| 1 | +$12.2M | |
| 2 | +$882K | |
| 3 | +$637K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$620K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$484K |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$3.89M | |
| 3 | -$1.01M | |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$876K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$612K |